Vascular endothelial growth factor and fibroblast growth factor-2 incorporation in starch-based bone tissue-engineered constructs promote the in vivo expression of neovascularization mediators

Tissue Engineering - Part A

Volumn 19, Issue 7-8, 2013, Pages 834-848

  Santos, Tírcia C ^a,b   Morton, Tatjana J ^b   Moritz, Martina ^b   Pfeifer, Sabine ^b   Reise, Kathrin ^b   Marques, Alexandra P ^a   Castro, António G ^a,c   Reis, Rui L ^a   Van Griensven, Martijn ^b,d  

^a UNIVERSITY OF MINHO   (Portugal)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c UNIVERSITY OF MINHO   (Portugal)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; GLYCOPROTEINS; GROWTH KINETICS; SEALANTS; STEM CELLS; TISSUE;

ADIPOSE DERIVED STEM CELLS; CHAIN REACTION; FIBRIN SEALANTS; FIBROBLAST GROWTH FACTOR-2; GROWTH FACTOR; HISTOLOGICAL ANALYSIS; IN-VIVO; INFLAMMATORY REACTION; INTERFERON-GAMMA; INTERLEUKIN-4; LONG-TERM OUTCOME; NEO-VASCULARIZATION; STARCH-BASED; TISSUE-ENGINEERED CONSTRUCTS; TRANSGENIC MICE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION; VEGFR-2; WET SPINNING;

SCAFFOLDS (BIOLOGY);

FIBROBLAST GROWTH FACTOR 2; POLYCAPROLACTONE; POLYESTER; STARCH; TISSUE SCAFFOLD; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; ANIMAL; ARTICLE; BONE; CELL TRACKING; CHEMISTRY; DRUG EFFECT; FEMALE; HUMAN; LUMINESCENCE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; MOUSE; NUDE MOUSE; TISSUE ENGINEERING; TRANSGENIC MOUSE;

ADULT; ANIMALS; BONE AND BONES; CELL TRACKING; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LUMINESCENT MEASUREMENTS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; STARCH; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84874685019     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0741     Document Type: Article

References (66)

1. Mikos, A.G., Herring, S.W., Ochareon, P., Elisseeff, J., Lu, H.H., Kandel, R., et al. Engineering complex tissues. Tissue Eng 12, 3307, 2006.
2. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
3. Gomes, M.E., Azevedo, H.S., Moreira, A.R., Ella, V., Kellomaki, M., and Reis, R.L. Starch-poly(epsilon-caprolactone) and starch-poly(lactic acid) fibre-mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour. J Tissue Eng Regen Med 2, 243, 2008.
4. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
5. Peters, M.C., Polverini, P.J., and Mooney, D.J. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 60, 668, 2002.
6. Kaigler, D., Krebsbach, P.H., Polverini, P.J., and Mooney, D.J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9, 95, 2003.
7. Martins, A.M., Pham, Q.P., Malafaya, P.B., Sousa, R.A., Gomes, M.E., Raphael, R.M., et al. The role of lipase and alpha-amylase in the degradation of starch/poly(epsiloncaprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. Tissue Eng Part A 15, 295, 2009.
8. Tuzlakoglu, K., Pashkuleva, I., Rodrigues, M.T., Gomes, M.E., van Lenthe, G.H., Muller, R., et al. A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. J Biomed Mater Res A 92, 369, 2010.
9. Gerber, H.P., and Ferrara, N. Angiogenesis and bone growth. Trends Cardiovasc Med 10, 223, 2000.
10. Hausman, M.R., Schaffler, M.B., and Majeska, R.J. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29, 560, 2001.
11. Fuchs, S., Ghanaati, S., Orth, C., Barbeck, M., Kolbe, M., Hofmann, A., et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30, 526, 2009.
12. Gomes, M.E., Sikavitsas, V.I., Behravesh, E., Reis, R.L., and Mikos, A.G. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starchbased three-dimensional scaffolds. J Biomed Mater Res A 67, 87, 2003.
13. Jabbarzadeh, E., Starnes, T., Khan, Y.M., Jiang, T., Wirtel, A.J., Deng, M., et al. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: a combined gene therapy-cell transplantation approach. Proc Natl Acad Sci U S A 105, 11099, 2008.
14. Santos, M.I., Unger, R.E., Sousa, R.A., Reis, R.L., and Kirkpatrick, C.J. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials 30, 4407, 2009.
15. Unger, R.E., Sartoris, A., Peters, K., Motta, A., Migliaresi, C., Kunkel, M., et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 28, 3965, 2007.
16. Tao, J., Sun, Y., Wang, Q.G., and Liu, C.W. Induced endothelial cells enhance osteogenesis and vascularization of mesenchymal stem cells. Cells Tissues Organs 190, 185, 2009.
17. Yang, P., Wang, C., Shi, Z., Huang, X., Dang, X., Xu, S., et al. Prefabrication of vascularized porous three-dimensional scaffold induced from rhVEGF(165): a preliminary study in rats. Cells Tissues Organs 189, 327, 2009.
18. Schumann, P., Tavassol, F., Lindhorst, D., Stuehmer, C., Bormann, K.H., Kampmann, A., et al. Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. Microvasc Res 78, 180, 2009.
19. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623, 1999.
20. Elcin, Y.M., Dixit, V., and Gitnick, G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs 25, 558, 2001.
21. Fujita, M., Ishihara, M., Simizu, M., Obara, K., Ishizuka, T., Saito, Y., et al. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25, 699, 2004.
22. Nakamura, S., Nambu, M., Ishizuka, T., Hattori, H., Kanatani, Y., Takase, B., et al. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 85, 619, 2008.
23. Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Masuoka, K., et al. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A 64, 551, 2003.
24. Martins, A.M., Pham, Q.P., Malafaya, P.B., Sousa, R.A., Gomes, M.E., Raphael, R.M., et al. The role of lipase and alpha-amylase in the degradation of starch/poly(varepsiloncaprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. Tissue Eng Part A 15, 295, 2009.
25. Morton, T.J., Furst, W., van Griensven, M., and Redl, H. Controlled release of substances bound to fibrin-anchors or of DNA. Drug Deliv 16, 102, 2009.
26. Rada, T., Reis, R.L., and Gomes, M.E. Adipose tissuederived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev 15, 113, 2009.
27. Quarto, N., and Longaker, M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12, 1405, 2006.
28. Ehrbar, M., Zeisberger, S.M., Raeber, G.P., Hubbell, J.A., Schnell, C., and Zisch, A.H. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 29, 1720, 2008.
29. Balmayor, E.R., Tuzlakoglu, K., Azevedo, H.S., and Reis, R.L. Preparation and characterization of starch-poly-epsiloncaprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications. Acta Biomater 5, 1035, 2009.
30. Balmayor, E.R., Tuzlakoglu, K., Marques, A.P., Azevedo, H.S., and Reis, R.L. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents. J Mater Sci Mater Med 19, 1617, 2008.
31. Wolbank, S., Peterbauer, A., Fahrner, M., Hennerbichler, S., van Griensven, M., Stadler, G., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13, 1173, 2007.
32. Suga, H., Shigeura, T., Matsumoto, D., Inoue, K., Kato, H., Aoi, N., et al. Rapid expansion of human adipose-derived stromal cells preserving multipotency. Cytotherapy 9, 738, 2007.
33. Wolbank, S., Peterbauer, A., Wassermann, E., Hennerbichler, S., Voglauer, R., van Griensven, M., et al. Labelling of human adipose-derived stem cells for non-invasive in vivo cell tracking. Cell Tissue Bank 8, 163, 2007.
34. Reis, R.L., Mendes, S.C., Cunha, A.M., and Bevis, M.L. Processing and in vitro degradation of starch/EVOH thermoplastic blends. Polym Int 43, 347, 1997.
35. Goessl, A., and Redl, H. Optimized thrombin dilution protocol for a slowly setting fibrin sealant in surgery. Eur Surg 37, 43, 2005.
36. Zhang, N., Fang, Z., Contag, P.R., Purchio, A.F., and West, D.B. Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 103, 617, 2004.
37. Maeda, K., Chung, Y.S., Takatsuka, S., Ogawa, Y., Onoda, N., Sawada, T., et al. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72, 319, 1995.
38. Kirkwood, B., and Sterne, J. Essential Medical Statistics, second edition. Hoboken, NJ: Wiley, 2003.
39. Hofmann, A., Ritz, U., Verrier, S., Eglin, D., Alini, M., Fuchs, S., et al. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials 29, 4217, 2008.
40. Egana, J.T., Fierro, F.A., Kruger, S., Bornhauser, M., Huss, R., Lavandero, S., et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffoldbased dermal regeneration. Tissue Eng Part A 15, 1191, 2009.
41. Gomes, M.E., Holtorf, H.L., Reis, R.L., and Mikos, A.G. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 12, 801, 2006.
42. Santos, M.I., Fuchs, S., Gomes, M.E., Unger, R.E., Reis, R.L., and Kirkpatrick, C.J. Response of micro-and macrovascular endothelial cells to starch-based fiber meshes for bone tissue engineering. Biomaterials 28, 240, 2007.
43. Santos, M.I., Tuzlakoglu, K., Fuchs, S., Gomes, M.E., Peters, K., Unger, R.E., et al. Endothelial cell colonization and angiogenic potential of combined nano-and micro-fibrous scaffolds for bone tissue engineering. Biomaterials 29, 4306, 2008.
44. Byk, T., Haddada, H., Vainchenker, W., and Louache, F. Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells. Hum Gene Ther 9, 2493, 1998.
45. Marit, G., Cao, Y., Froussard, P., Ripoche, J., Dupouy, M., Elandaloussi, A., et al. Increased liposome-mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayers. Eur J Haematol 64, 22, 2000.
46. Domashenko, A., Gupta, S., and Cotsarelis, G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 18, 420, 2000.
47. Daldrup-Link, H.E., Rudelius, M., Oostendorp, R.A., Jacobs, V.R., Simon, G.H., Gooding, C., et al. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad Radiol 12, 502, 2005.
48. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N.P., Risau, W., et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835, 1993.
49. Rissanen, T.T., Vajanto, I., Hiltunen, M.O., Rutanen, J., Kettunen, M.I., Niemi, M., et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 160, 1393, 2002.
50. Mittermayr, R., Morton, T., Hofmann, M., Helgerson, S., van Griensven, M., and Redl, H. Sustained (rh)VEGF(165) release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis. Wound Repair Regen 16, 542, 2008.
51. Martin, P. Wound healing -aiming for perfect skin regeneration. Science 276, 75, 1997.
52. Dvorak, H.F., Brown, L.F., Detmar, M., and Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146, 1029, 1995.
53. Risau, W. Mechanisms of angiogenesis. Nature 386, 671, 1997.
54. Santos, T.C., Marques, A.P., Horing, B., Martins, A.R., Tuzlakoglu, K., Castro, A.G., et al. In vivo short-term and longterm host reaction to starch-based scaffolds. Acta Biomater 6, 4314, 2010.
55. Clauss, M., Weich, H., Breier, G., Knies, U., Rockl, W., Waltenberger, J., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271, 17629, 1996.
56. Barleon, B., Sozzani, S., Zhou, D., Weich, H.A., Mantovani, A., and Marme, D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336, 1996.
57. Shen, H., Clauss, M., Ryan, J., Schmidt, A.M., Tijburg, P., Borden, L., et al. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81, 2767, 1993.
58. van Bilsen, P.H., Krenning, G., Billy, D., Duval, J.L., Huurdeman-Vincent, J., and van Luyn, M.J. Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction. Colloids Surf B Biointerfaces 67, 46, 2008.
59. Yamakawa, N., Tanaka, T., Shigeta, M., Hamano, M., and Usui, M. Surface roughness of intraocular lenses and inflammatory cell adhesion to lens surfaces. J Cataract Refract Surg 29, 367, 2003.
60. Buschmann, I., Heil, M., Jost, M., and Schaper, W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10, 371, 2003.
61. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003.
62. Maharaj, A.S., Saint-Geniez, M., Maldonado, A.E., and D'Amore, P.A. Vascular endothelial growth factor localization in the adult. Am J Pathol 168, 639, 2006.
63. Folkman, J., and Shing, Y. Angiogenesis. J Biol Chem 267, 10931, 1992.
64. Brown, L.F., Yeo, K.T., Berse, B., Yeo, T.K., Senger, D.R., Dvorak, H.F., et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176, 1375, 1992.
65. Brown, L.F., Olbricht, S.M., Berse, B., Jackman, R.W., Matsueda, G., Tognazzi, K.A., et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 154, 2801, 1995.
66. Ornitz, D.M., and Itoh, N. Fibroblast growth factors. Genome Biol 2, REVIEWS 3005, 2001.